{"text": "#merck announces thirdquarter 2017 dividend. read more: URL $mrk"}
{"text": "rt AT_USER keytruda approval juggernaut rolls on, as AT_USER okays use in any solid tumor marked by a genetic feature: URL"}
{"text": "rt AT_USER AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo $amgn\u00a1\u00ad"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "rt AT_USER in a first, fda clears merck's keytruda for cancers based on genetics, not location URL $mrk"}
{"text": "rt AT_USER $mrk \u00a1\u00aa fda grants first-time accelerated approval to keytruda for solid tumors with two genetic features msi-h and dmmr."}
{"text": "rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild\u00a1\u00ad"}
{"text": "rt AT_USER nice story from AT_USER on $mrk's latest keytruda approval URL"}
{"text": "rt AT_USER AT_USER stick around for topline p3 data few weeks past #asco dcvaxl combo #opdivo #keytruda $bmy $mrk $rhhby $a\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo $amgn\u00a1\u00ad"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "rt AT_USER AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo $amgn\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER stick around for topline p3 data few weeks past #asco dcvaxl combo #opdivo #keytruda $bmy $mrk $rhhby $a\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER $incy $mrk $bmy $icpt $juno $kite $blue $cncr investors need to focus on $nwbo #asco phase 3 dcvaxl up\u00a1\u00ad"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "do you know that #book value for $mrk is $14.58 URL"}
{"text": "fda approves #merck's keytruda to treat cancers with genetic defects. read more: URL $mrk"}
{"text": "rt AT_USER .AT_USER releases pre #asco17 report; $rog $azn $tsro $pfe $lly $abbv $bmy $mrk  URL #bpi\u00a1\u00ad"}
{"text": "merck presents phase ii data on chronic cough candidate URL $mrk $regn $bayry"}
{"text": "#merck vs. sanofi: which stock is a better pick post q1 earnings? - may 22, 2017. read more: URL $mrk"}
{"text": "rt AT_USER AT_USER $mrk catalysts URL"}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "rt AT_USER nice story from AT_USER on $mrk's latest keytruda approval URL"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "rt AT_USER nice story from AT_USER on $mrk's latest keytruda approval URL"}
{"text": "megtirrell: nice story from benthefidler on $mrk's latest keytruda approval URL"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "nice story from AT_USER on $mrk's latest keytruda approval URL"}
{"text": "rt AT_USER $loxo and $rxdx both following $mrk regulatory path seeking fda approval based on genetic feature of cancer, not organ\u00a1\u00ad"}
{"text": "rt AT_USER merck's gardasil preps for head-to-head with gsk\u00a1\u00afs cervarix in china, with big sales targets ahead URL"}
{"text": "rt AT_USER merck's remicade discounting put squeeze on biosims\u00a1\u00aaand broke u.k. law, officials say URL $mrk"}
{"text": "rt AT_USER fresh off two new fda nods, merck's high-flying keytruda nets priority status in stomach cancer URL $\u00a1\u00ad"}
{"text": "rt AT_USER announcing our 3q 2017 dividend: URL $mrk"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "$mrk - ppt - tax reform (u.s.) trump calls for deep cuts in business taxes, changes for individuals donald trumps - URL"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "$mrk bullish engulfing in my ib .. i think that includes ah"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "rt AT_USER fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "rt AT_USER #asco2017 is right around the corner. here's what to look out for URL $amgn $incy $juno $kite $lly $\u00a1\u00ad"}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "AT_USER $mrk catalysts URL"}
{"text": "rt AT_USER $loxo and $rxdx both following $mrk regulatory path seeking fda approval based on genetic feature of cancer, not organ\u00a1\u00ad"}
{"text": "fda landmark nod: cancer drug to match tumor genes, not tissue type URL $mrk"}
{"text": "wondering about risks of $mrk? the 21-day volatility is 3.67% URL"}
{"text": "rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER stick around for topline p3 data few weeks past #asco dcvaxl combo #opdivo #keytruda $bmy $mrk $rhhby $a\u00a1\u00ad"}
{"text": "rt AT_USER 5 things for #pharma #marketers to know: tues., may 23 #hcsm #disease #awareness $azn #asthma #fda $regn $sny $mrk URL"}
{"text": "5 things for #pharma #marketers to know: tues., may 23 #hcsm #disease #awareness $azn #asthma #fda $regn $sny $mrk\u00a1\u00ad URL"}
{"text": "rt AT_USER AT_USER stick around for topline p3 data few weeks past #asco dcvaxl combo #opdivo #keytruda $bmy $mrk $rhhby $a\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo $amgn\u00a1\u00ad"}
{"text": "rt AT_USER this could be in the top 50 disruptive technologies this year.  #dcvax $nwbo $juno $kite $blue $agio $celg $gild $bmy $nvs\u00a1\u00ad"}
{"text": "rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild\u00a1\u00ad"}
{"text": "in a first, fda clears merck's keytruda for cancers based on genetics, not location URL $mrk"}
{"text": "rt AT_USER this could be in the top 50 disruptive technologies this year.  #dcvax $nwbo $juno $kite $blue $agio $celg $gild $bmy $nvs\u00a1\u00ad"}
{"text": "rt AT_USER $mrk \u00a1\u00aa fda grants first-time accelerated approval to keytruda for solid tumors with two genetic features msi-h and dmmr."}
{"text": "$mrk company confirmed fda approved a new indication for keytruda - in the treatment of adult and pediatric patien\u00a1\u00ad URL"}
{"text": "rt AT_USER $loxo and $rxdx both following $mrk regulatory path seeking fda approval based on genetic feature of cancer, not organ\u00a1\u00ad"}
{"text": "$mrk: merck: fda grants accelerated approval to pembrolizumab for first tissue/site agnostic indication URL"}
{"text": "rt AT_USER merck's keytruda picks up a trifecta with fda approval to treat rare tumor type: URL $mrk #pharma"}
{"text": "merck's keytruda picks up a trifecta with fda approval to treat rare tumor type: URL $mrk #pharma"}
{"text": "#options #maxpain chart for $mrk. free options app URL URL"}
{"text": "rt AT_USER $mrk keytruda for microsatellite instability-high or mismatch repair deficient tumors is AT_USER first tissue/site-a\u00a1\u00ad"}
{"text": "$mrk #options oi chart. free stocks app URL URL"}
{"text": "AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo\u00a1\u00ad URL"}
{"text": "rt AT_USER $mrk \u00a1\u00aa fda grants first-time accelerated approval to keytruda for solid tumors with two genetic features msi-h and dmmr."}
{"text": "AT_USER stick around for topline p3 data few weeks past #asco dcvaxl combo #opdivo #keytruda $bmy $mrk $rhhby\u00a1\u00ad URL"}
{"text": "rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild\u00a1\u00ad"}
{"text": "rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild\u00a1\u00ad"}
{"text": "rt AT_USER valeant's ceo said today that aging demographics is positive for valeant especially for eye biz-b&amp;l $vrx $agn $myl $mrk $jn\u00a1\u00ad"}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "rt AT_USER $mrk #keytruda 1st drug ok'd by #fda based on common biomarker rather than location in body where tumor originated URL"}
{"text": "$mrk #keytruda ok for unresectable/metastatic solid tumors identified w/ microsatellite instability-high/mismatch r\u00a1\u00ad URL"}
{"text": "rt AT_USER $loxo and $rxdx both following $mrk regulatory path seeking fda approval based on genetic feature of cancer, not organ\u00a1\u00ad"}
{"text": "$mrk #keytruda 1st drug ok'd by #fda based on common biomarker rather than location in body where tumor originated URL"}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "$mrk fda approval news nice URL"}
{"text": "rt AT_USER $mrk\u00a1\u00afs keytruda granted fda accelerated nod for all unresectable/metastatic solid tumors w/ msi-h or dmmr biomarker, regardle\u00a1\u00ad"}
{"text": "top #sentiment for #sp1500 #stocks at market close: $t $mrk $cbs $lmt $rtn (2017/05/23) #stocktrading #predictiveanalytics #bigdata"}
{"text": "top sentiment for sp1500 stocks at market close: $t $mrk $cbs $lmt $rtn (2017/05/23) #sentiment #stock #alexandria"}
{"text": "#merck pharmaceuticals giant msd accused of breaching competition law. read more: URL $mrk"}
{"text": "so this happened fast: #fda clears #merck's #keytruda for cancer patients with certain biomarkers URL via AT_USER $mrk"}
{"text": "URL &lt;&lt; i\u00a1\u00afve reviewed the best stock alert services so you don\u00a1\u00aft have to! $srpt $fb $myl $mrk"}
{"text": ".AT_USER releases pre #asco17 report; $rog $azn $tsro $pfe $lly $abbv $bmy $mrk  URL #bpinews #oncology #cancer"}
{"text": "unicorn bay rating for $mrk is 2.94 out of 5. URL"}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "rt AT_USER $loxo and $rxdx both following $mrk regulatory path seeking fda approval based on genetic feature of cancer, not organ\u00a1\u00ad"}
{"text": "$mrk the fda just took an entirely new approach to approving a cancer drug URL"}
{"text": "rt AT_USER $mrk keytruda for microsatellite instability-high or mismatch repair deficient tumors is AT_USER first tissue/site-a\u00a1\u00ad"}
{"text": "$mrk\u00a1\u00afs keytruda granted fda accelerated nod for all unresectable/metastatic solid tumors w/ msi-h or dmmr biomarker, regardless of location"}
{"text": "the $cncr etf holds innovators that are at the forefront of cancer immunotherapy research like $mrk.\u00a1\u00ad URL"}
{"text": "$mrk - fda oks merck's keytruda for solid tumors URL"}
{"text": "uk competition watchdog accuses #merck of obstructing biosimilars. read more: URL $mrk"}
{"text": "uk watchdog accuses #merck of restricting biosimilar competition. read more: URL $mrk"}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "rt AT_USER $loxo and $rxdx both following $mrk regulatory path seeking fda approval based on genetic feature of cancer, not organ\u00a1\u00ad"}
{"text": "rt AT_USER keytruda approval juggernaut rolls on, as AT_USER okays use in any solid tumor marked by a genetic feature: URL"}
{"text": "yesterday i was telling my 12 year old about $mrk and keytruda :).. and all the combo experiements out there.."}
{"text": "rt AT_USER pretty standard day for $mrk. they got a pdufa for a new indication in the morning and a historic approval in the afternoon\u00a1\u00ad"}
{"text": "merck &amp; co., inc. $mrk announces quarterly dividend of $0.47 URL"}
